Ansell Limited (ASX:ANN)
Australia · Delayed Price · Currency is AUD 34.28
+0.49 (1.45%)
Oct 28, 2025, 4:19 PM AEST
Ansell Market Cap
Ansell has a market cap or net worth of 4.91 billion as of October 28, 2025. Its market cap has increased by 8.86% in one year.
Market Cap
4.91B
Enterprise Value
5.81B
Revenue
3.06B
Ranking
n/a
PE Ratio
32.34
Stock Price
34.28
Market Cap Chart
Since January 16, 1992, Ansell's market cap has decreased from 5.00B to 4.91B, a decrease of -1.64%. That is a compound annual growth rate of -0.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 4.91B | 0.43% |
| Dec 31, 2024 | 4.89B | 56.70% |
| Dec 29, 2023 | 3.12B | -12.08% |
| Dec 30, 2022 | 3.55B | -11.25% |
| Dec 31, 2021 | 4.00B | -10.48% |
| Dec 31, 2020 | 4.47B | 18.30% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 102.70B |
| Pro Medicus | 29.45B |
| Cochlear | 18.98B |
| Sonic Healthcare | 10.75B |
| Ramsay Health Care | 7.34B |
| Telix Pharmaceuticals | 5.59B |
| Mesoblast | 3.30B |
| Neuren Pharmaceuticals | 2.71B |